Search Results 1351-1360 of 19431 for Hemoglobin

1. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

   Hemoglobin ≥ 8 gm/dl;; Calculated (Calc.) creatinine clearance ≥ 45 mL/min;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN);; Aspartate ...

2. PRE-I-SPY Phase I/Ib Oncology Platform Program - Mayo Clinic

   - Hemoglobin ≥ 9.0 g/dL with no blood transfusion in the past 28 days - Total bilirubin ≤ 1.5 x the upper limit of normal (ULN) - Aspartate ...

3. A Study to Evaluate the Effectiveness and Safety of Brolucizumab vs. Aflibercept in Patients with Visual Impairment Due to Diabetic Macular Edema - Mayo Clinic

   Patients with type 1 or type 2 diabetes mellitus (DM) and Hemoglobin A1c (HbA1c) ≤ 12% at screening. Study eye: Visual impairment due to DME with: Best ...

4. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

   Hemoglobin levels ≤ 8.0 or ≥ 18.0 g/dL for men and > 15 for women at Screening, with hematocrit ≥ 54% for men and ≥ 45% for women; Current malignancy ...

5. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

   ... hemoglobin). Subjects with scleroderma renal crisis within 6 months of screening. Subjects with a concomitant life-threatening disease with a life ...

6. Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL. Serum albumin ≥ 3.5 g/dL. Subjects with tumors potentially highly sensitive to tipifarnib (HRAS mutant VAF ≥35%) may be enrolled ...

7. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Hemoglobin (HgB) > 9.0 g/dL; Total bilirubin ≤ 1.5 times upper limit of normal (ULN). For total bilirubin > 1.5 times ULN, the direct bilirubin must be ...

8. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Platelets ≥ 100,000/mcL;; Total bilirubin ≤ 1.5 x the upper limit of normal (ULN);; SGPT (ALT) or SGOT (AST) ≤ 2.5 x ULN in the ...

9. Leucovorin (intramuscular route, intravenous route) - Side effects & uses - Mayo Clinic

   Leucovorin injection is used as a rescue after high-dose methotrexate treatment. This medicine is also used to lessen the toxic effects of methotrexate in ...

10. Dasatinib (oral route) - Side effects & dosage - Mayo Clinic

    It is also used to treat Ph+ CML and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in adults after other medicines (eg, imatinib) or ...